Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Conservative approach for significant valvular heart disease – how grim is the prognosis?
Session:
Sessão de Posters 52 - Intervenção na doença valvular
Speaker:
Carolina Pereira Mateus
Congress:
CPC 2024
Topic:
H. Interventional Cardiology and Cardiovascular Surgery
Theme:
25. Interventional Cardiology
Subtheme:
25.3 Non-coronary Cardiac Intervention
Session Type:
Cartazes
FP Number:
---
Authors:
Carolina Pereira Mateus; Inês Fialho; Joana Lima Lopes; Mariana Passos; Filipa Gerardo; Márcio Madeira; João Bicho Augusto; Miguel Santos; Sérgio Bravo Baptista; Pedro Farto e Abreu; Carlos Morais; José Neves
Abstract
<p>Introduction:</p> <p>The Heart Team (HT) has the goal of defining the best treatment for each patient, sometimes recommending a conservative approach. The goal of this study was to compare the outcomes of valvular heart disease (VHD) patients proposed for a conservative vs interventional approach in a contemporary dedicated HT meeting.</p> <p>Methods:</p> <p>A single-center study included all consecutive patients evaluated by the valvular HT from January 2018 to June 2021. Demographics, comorbidities, therapeutic decisions, and major adverse cardiovascular events (MACE, i.e. all-cause mortality, stroke, myocardial infarction, hospital readmission and worsening heart failure) at 6 months after the HT meeting were analyzed. Group comparisons used appropriate statistical tests, and survival analysis employed the Mantel-Cox log-rank test.</p> <p>Results:</p> <p>A total of 312 patients with VHD were discussed in the HT meeting. A final decision of a conservative approach (CA) was made for 8.0% of patients (n=24), and interventional approach (IA) in 92.0% (n=287) of patients (surgery in 63.4% and percutaneous valvular interventions in 36.6%). The baseline characteristics from both groups are summarized in Tab. 1: patients in the CA group were significantly older (79.3±9.7 vs 73.6±12.4 years, p=0.029), had a higher prevalence of significant pulmonary hypertension (37.5 vs 15.8%, p=0.007), infective endocarditis (20.8 vs 4.9%, p=0.002) and higher EuroScore II (median 6.7 [3.0–16.8] vs 3.5 [1.8–5.8]%, p=0.003). The CA group showed significantly lower six-month survival free from all-cause mortality (45.8 vs 12.6%, log-rank p<0.001; Fig. 1A) and MACE (52.2 vs 25.7%, log-rank p=0.002; Fig. 1B).</p> <p>Conclusion:</p> <p>In a contemporary valvular HT meeting cohort, patients recommended a conservative approach faced a grimmer prognosis at 6 months, with nearly half experiencing major short-term events. These findings highlight the importance of close follow-up and dedicated palliative strategies in patient subgroup.</p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site